Xponance Inc. Buys 5,090 Shares of Royalty Pharma plc (NASDAQ:RPRX)

Xponance Inc. grew its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 38.8% in the third quarter, HoldingsChannel.com reports. The fund owned 18,218 shares of the biopharmaceutical company’s stock after acquiring an additional 5,090 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $494,000 at the end of the most […]

Related Keywords

United States ,Roryb Riggs , ,Carson Advisory Inc ,Avara Management Ltd ,Acadian Asset Management ,Morgan Stanley ,Xponance Inc ,Associates Corp ,Nasdaq ,Royalty Pharma ,Free Report ,Financial Advisors ,Asset Management ,Director Rory ,Get Free Report ,Visit Holdingschannel ,Royalty Pharma Daily ,Nasdaq Rprx ,Rprx ,Finance ,76028h20 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,